These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7074585)
1. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy. Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585 [TBL] [Abstract][Full Text] [Related]
2. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy. Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707 [TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy. Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917 [TBL] [Abstract][Full Text] [Related]
4. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584 [TBL] [Abstract][Full Text] [Related]
5. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer. Lamerz R; Leonhardt A; Ehrhart H; von Lieven H Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen. Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201 [TBL] [Abstract][Full Text] [Related]
7. Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease. Yau T; Wong H; Chan P; Chan T; Mak J; Epstein RJ Clin Colorectal Cancer; 2010 Apr; 9(2):108-12. PubMed ID: 20378505 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of serial carcinoembryonic antigen (CEA) determinations in monitoring chemotherapy. Young VL; Kashmiri R; Hazen ZR; Meeker WR South Med J; 1976 Oct; 69(10):1274-6. PubMed ID: 982100 [TBL] [Abstract][Full Text] [Related]
9. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982 [TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer]. Paulick R; Caffier H Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751 [TBL] [Abstract][Full Text] [Related]
12. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)]. Pompecki R; Schröder G; Garbrecht M; Frahm H Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696 [TBL] [Abstract][Full Text] [Related]
13. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse. Lokich JJ; Zamcheck N; Lowenstein MW Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986 [TBL] [Abstract][Full Text] [Related]
14. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer. Staab HJ; Ahlemann LM; Koch HL; Anderer FA Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702 [TBL] [Abstract][Full Text] [Related]
15. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy. Theriault RL; Hortobagyi GN; Fritsche HA; Frye D; Martinez R; Buzdar AU Cancer; 1989 Mar; 63(5):828-35. PubMed ID: 2914290 [TBL] [Abstract][Full Text] [Related]
16. Serial tests of carcinoembryonic antigen in patients with breast cancer. Lee YT Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246 [TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients. Veronesi A; Talamini R; Longhi S; Crivellari D; Galligioni E; Tirelli U; Trovò MG; Magri MD; Frustaci S; Figoli F; Zagonel V; Tumolo S; Grigoletto E Tumori; 1982 Dec; 68(6):477-80. PubMed ID: 7168012 [TBL] [Abstract][Full Text] [Related]
18. Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance? Lawrence N; Hinder V; Murray M; Macapagal J; Thompson P; Sharples K; Findlay M Asia Pac J Clin Oncol; 2017 Apr; 13(2):e124-e131. PubMed ID: 26245738 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Haagensen DE; Kister SJ; Vandevoorde JP; Gates JB; Smart EK; Hansen HJ; Wells SA Cancer; 1978 Sep; 42(3 Suppl):1512-9. PubMed ID: 709523 [TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen as a monitor of recurrent breast cancer. Lee YT J Surg Oncol; 1982 Jun; 20(2):109-14. PubMed ID: 7078191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]